Literature DB >> 7611103

Low-dosage dobutamine magnetic resonance imaging as an alternative to echocardiography in the detection of viable myocardium after acute infarction.

P A Dendale1, P R Franken, G J Waldman, D G De Moor, D A Tombeur, P F Block, A De Roos.   

Abstract

The objective of this study was the evaluation of the feasibility of magnetic resonance (MR) imaging of the heart with low-dosage dobutamine stimulation for the detection of viability after acute myocardial infarction. Gradient echo MR images were obtained in 37 patients with recent myocardial infarction. Images of wall motion abnormalities and their reaction to low-dosage dobutamine stimulation were analyzed and compared with two-dimensional echocardiograms. Follow-up echocardiography at 3 to 6 months was available in 24 patients. Concordant diagnosis of viability between the two techniques was obtained in 30 (81%) of 37 patients. MR correctly predicted evolution of wall motion in 19 (79%) of 24 patients, a result not significantly different from echocardiography: 20 (83%) of 24. It was concluded that low-dosage dobutamine MR imaging is a safe alternative to echocardiography to predict recovery of wall motion abnormalities after myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7611103     DOI: 10.1016/0002-8703(95)90248-1

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  12 in total

1.  Infarct zone viability influences ventricular remodelling after late recanalisation of an occluded infarct related artery.

Authors:  N G Bellenger; Z Yousef; K Rajappan; M S Marber; D J Pennell
Journal:  Heart       Date:  2005-04       Impact factor: 5.994

2.  Prediction of myocardial recovery by dobutamine magnetic resonance imaging and delayed enhancement early after reperfused acute myocardial infarction.

Authors:  Achim A Barmeyer; Alexander Stork; Martin Bansmann; Kai Muellerleile; Mirko Heuer; Markus Bavastro; Gerhard Adam; Thomas Meinertz; Gunnar K Lund
Journal:  Eur Radiol       Date:  2007-08-14       Impact factor: 5.315

3.  Assessment of myocardial viability in a porcine model of chronic coronary artery stenosis with dual dose dobutamine magnetic resonance imaging.

Authors:  S Dymarkowski; M Szilard; A Maes; X S Liu; Y M Huang; E Verbeken; L Mortelmans; J Bogaert; I De Scheerder
Journal:  Int J Cardiovasc Imaging       Date:  2003-02       Impact factor: 2.357

Review 4.  Post myocardial infarction of the left ventricle: the course ahead seen by cardiac MRI.

Authors:  Pier Giorgio Masci; Jan Bogaert
Journal:  Cardiovasc Diagn Ther       Date:  2012-06

5.  Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2005-10-01

6.  Cardiac magnetic resonance imaging in patients with coronary disease.

Authors:  Henry D Wu; Raymond Y Kwong
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-02

Review 7.  Current clinical relevance of cardiovascular magnetic resonance and its relationship to nuclear cardiology.

Authors:  E E van der Wall; J Bax
Journal:  J Nucl Cardiol       Date:  1999 Jul-Aug       Impact factor: 3.872

8.  Clinical assessment of myocardial viability using MRI during a constant infusion of Gd-DTPA.

Authors:  R S Pereira; G Wisenberg; F S Prato; K Yvorchuk
Journal:  MAGMA       Date:  2000-12       Impact factor: 2.533

Review 9.  The 20 year evolution of dobutamine stress cardiovascular magnetic resonance.

Authors:  Charaslak Charoenpanichkit; W Gregory Hundley
Journal:  J Cardiovasc Magn Reson       Date:  2010-10-26       Impact factor: 5.364

10.  The emerging role of magnetic resonance imaging and multidetector computed tomography in the diagnosis of dilated cardiomyopathy.

Authors:  Massimo Slavich; Anca Florian; Jan Bogaert
Journal:  Insights Imaging       Date:  2011-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.